Literature DB >> 16420040

Novel procedure for modeling ligand/receptor induced fit effects.

Woody Sherman1, Tyler Day, Matthew P Jacobson, Richard A Friesner, Ramy Farid.   

Abstract

We present a novel protein-ligand docking method that accurately accounts for both ligand and receptor flexibility by iteratively combining rigid receptor docking (Glide) with protein structure prediction (Prime) techniques. While traditional rigid-receptor docking methods are useful when the receptor structure does not change substantially upon ligand binding, success is limited when the protein must be "induced" into the correct binding conformation for a given ligand. We provide an in-depth description of our novel methodology and present results for 21 pharmaceutically relevant examples. Traditional rigid-receptor docking for these 21 cases yields an average RMSD of 5.5 A. The average ligand RMSD for docking to a flexible receptor for the 21 pairs is 1.4 A; the RMSD is < or =1.8 A for 18 of the cases. For the three cases with RMSDs greater than 1.8 A, the core of the ligand is properly docked and all key protein/ligand interactions are captured.

Mesh:

Substances:

Year:  2006        PMID: 16420040     DOI: 10.1021/jm050540c

Source DB:  PubMed          Journal:  J Med Chem        ISSN: 0022-2623            Impact factor:   7.446


  491 in total

1.  Identification of a second substrate-binding site in solute-sodium symporters.

Authors:  Zheng Li; Ashley S E Lee; Susanne Bracher; Heinrich Jung; Aviv Paz; Jay P Kumar; Jeff Abramson; Matthias Quick; Lei Shi
Journal:  J Biol Chem       Date:  2014-11-14       Impact factor: 5.157

2.  Molecular mechanism of serotonin transporter inhibition elucidated by a new flexible docking protocol.

Authors:  Mari Gabrielsen; Rafał Kurczab; Aina W Ravna; Irina Kufareva; Ruben Abagyan; Zdzisław Chilmonczyk; Andrzej J Bojarski; Ingebrigt Sylte
Journal:  Eur J Med Chem       Date:  2011-10-20       Impact factor: 6.514

3.  Enzymatic deamination of the epigenetic base N-6-methyladenine.

Authors:  Siddhesh S Kamat; Hao Fan; J Michael Sauder; Stephen K Burley; Brian K Shoichet; Andrej Sali; Frank M Raushel
Journal:  J Am Chem Soc       Date:  2011-01-28       Impact factor: 15.419

4.  Receptor-guided 3D-QSAR approach for the discovery of c-kit tyrosine kinase inhibitors.

Authors:  Anna Maria Almerico; Marco Tutone; Antonino Lauria
Journal:  J Mol Model       Date:  2011-11-30       Impact factor: 1.810

5.  On achieving high accuracy and reliability in the calculation of relative protein-ligand binding affinities.

Authors:  Lingle Wang; B J Berne; Richard A Friesner
Journal:  Proc Natl Acad Sci U S A       Date:  2012-01-23       Impact factor: 11.205

6.  Pose prediction and virtual screening performance of GOLD scoring functions in a standardized test.

Authors:  John W Liebeschuetz; Jason C Cole; Oliver Korb
Journal:  J Comput Aided Mol Des       Date:  2012-02-28       Impact factor: 3.686

7.  Farnesyl pyrophosphate is an endogenous antagonist to ADP-stimulated P2Y₁₂ receptor-mediated platelet aggregation.

Authors:  Carl Högberg; Olof Gidlöf; Francesca Deflorian; Kenneth A Jacobson; Aliaa Abdelrahman; Christa E Müller; Björn Olde; David Erlinge
Journal:  Thromb Haemost       Date:  2012-05-25       Impact factor: 5.249

8.  Identification, structure modification, and characterization of potential small-molecule SGK3 inhibitors with novel scaffolds.

Authors:  Grace Qun Gong; Ke Wang; Xin-Chuan Dai; Yan Zhou; Rajesh Basnet; Yi Chen; De-Hua Yang; Woo-Jeong Lee; Christina Maree Buchanan; Jack Urquhart Flanagan; Peter Robin Shepherd; Ying Chen; Ming-Wei Wang
Journal:  Acta Pharmacol Sin       Date:  2018-07-23       Impact factor: 6.150

9.  Activation of atypical protein kinase C by sphingosine 1-phosphate revealed by an aPKC-specific activity reporter.

Authors:  Taketoshi Kajimoto; Alisha D Caliman; Irene S Tobias; Taro Okada; Caila A Pilo; An-Angela N Van; J Andrew McCammon; Shun-Ichi Nakamura; Alexandra C Newton
Journal:  Sci Signal       Date:  2019-01-01       Impact factor: 8.192

10.  Unique binding behavior of the recently approved angiotensin II receptor blocker azilsartan compared with that of candesartan.

Authors:  Shin-ichiro Miura; Atsutoshi Okabe; Yoshino Matsuo; Sadashiva S Karnik; Keijiro Saku
Journal:  Hypertens Res       Date:  2012-10-04       Impact factor: 3.872

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.